Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns

Psychiatry Research
2023
Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Steven Adelsheim, Cynthia Z. Burton, Cameron S. Carter, Tara Niendam, J. Daniel Ragland, Tamara G. Sale, Stephan F. Taylor, Ivy F. Tso, William R. McFarlane, & Barbara A. Cornblatt

Please use this link to access this publication: https://www.sciencedirect.com/science/article/abs/pii/S0165178123003700

Abstract

Recreational cannabis use has recently gained considerable interest as an environmental risk factor that triggers the onset of psychosis. To date, however, the evidence that cannabis is associated with negative outcomes in individuals at clinical high risk (CHR) for psychosis is inconsistent. The present study tracked cannabis usage over a 2-year period and examined its associations with clinical and neurocognitive outcomes, along with medication rates. CHR youth who continuously used cannabis had higher neurocognition and social functioning over time, and decreased medication usage, relative to non-users. Surprisingly, clinical symptoms improved over time despite the medication decreases.

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.